Aggressive Statins: the IDEAL Treatment
/
RSS Feed
Terje Pedersen
More evidence for the benefits of aggressive lipid-lowering with statins has come from the IDEAL study, which randomised nearly 9000 post-MI patients to either 80 mg of atorvastatin or 20/40 mg simvastatin daily. Terje Pedersen from Ulleval University Hospital in Norway presented the findings.
[audio:https://www.audiomedica.com/podcasting/aha2005/Terje_Pedersen.mp3]
You may also like...
RITA-3 Study Five Year Results: Aggressive Management of Acute Coronary Syndrome Now looks Even Better 12 Sep, 2005 - Audio Journal of Cardiovascular Medicine: reporting from American Heart Association Scientific Sessions, Chicago, November 12-15, 2006 16 Nov, 2006
- COURAGE Trial: Optimal Medical Therapy Alone is Sufficient for Patients with Stable Angina: Adding PCI Does Not Help – ILLUSTRATE Study Shows Torcetrapib Raises HDL But Fails to Lower Coronary Risk 26 Mar, 2007
- 50% of Women are Over-treated in Acute Coronary Syndromes 17 Nov, 2005
